{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:16:27Z","timestamp":1794078987267,"version":"4.8.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["234905"],"award-info":[{"award-number":["234905"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In myotonic dystrophy type 1 (DM1), deregulated alternative splicing of the muscle chloride channel Clcn1 causes myotonia, a delayed relaxation of muscles due to repetitive action potentials. The degree of weakness in adult DM1 is associated with increased frequency of oxidative muscle fibers. However, the mechanism for glycolytic-to-oxidative fiber type transition in DM1 and its relationship to myotonia are uncertain. Here we cross two mouse models of DM1 to create a double homozygous model that features progressive functional impairment, severe myotonia, and near absence of type 2B glycolytic fibers. Intramuscular injection of an antisense oligonucleotide for targeted skipping of\n                    <jats:italic>Clcn1<\/jats:italic>\n                    exon 7a corrects\n                    <jats:italic>Clcn1<\/jats:italic>\n                    alternative splicing, increases glycolytic 2B levels to \u2265 40% frequency, reduces muscle injury, and improves fiber hypertrophy relative to treatment with a control oligo. Our results demonstrate that fiber type transitions in DM1 result from myotonia and are reversible, and support the development of\n                    <jats:italic>Clcn1<\/jats:italic>\n                    -targeting therapies for DM1.\n                  <\/jats:p>","DOI":"10.1038\/s41467-023-37619-1","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T09:03:53Z","timestamp":1680858233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Correction of Clcn1 alternative splicing reverses muscle fiber type transition in mice with myotonic dystrophy"],"prefix":"10.1038","volume":"14","author":[{"given":"Ningyan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3957-2255","authenticated-orcid":false,"given":"Eunjoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layal","family":"Antoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thurman M.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,7]]},"reference":[{"key":"37619_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/WCO.0000000000000128","volume":"27","author":"C Turner","year":"2014","unstructured":"Turner, C. & Hilton-Jones, D. Myotonic dystrophy: diagnosis, management and new therapies. Curr. Opin. Neurol. 27, 599\u2013606 (2014).","journal-title":"Curr. Opin. Neurol."},{"key":"37619_CR2","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","volume":"68","author":"JD Brook","year":"1992","unstructured":"Brook, J. D. et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2032 end of a transcript encoding a protein kinase family member. Cell 68, 799\u2013808 (1992).","journal-title":"Cell"},{"key":"37619_CR3","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1083\/jcb.128.6.995","volume":"128","author":"KL Taneja","year":"1995","unstructured":"Taneja, K. L., McCurrach, M., Schalling, M., Housman, D. & Singer, R. H. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol. 128, 995\u20131002 (1995).","journal-title":"J. Cell Biol."},{"key":"37619_CR4","doi-asserted-by":"publisher","first-page":"7388","DOI":"10.1073\/pnas.94.14.7388","volume":"94","author":"BM Davis","year":"1997","unstructured":"Davis, B. M., McCurrach, M. E., Taneja, K. L., Singer, R. H. & Housman, D. E. Expansion of a CUG trinucleotide repeat in the 3\u2032 untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl Acad. Sci. USA 94, 7388\u20137393 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"37619_CR5","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1093\/hmg\/ddh327","volume":"13","author":"H Jiang","year":"2004","unstructured":"Jiang, H., Mankodi, A., Swanson, M. S., Moxley, R. T. & Thornton, C. A. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. 13, 3079\u20133088 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"37619_CR6","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1161\/01.RES.0000193598.89753.e3","volume":"97","author":"A Mankodi","year":"2005","unstructured":"Mankodi, A., Lin, X., Blaxall, B. C., Swanson, M. S. & Thornton, C. A. Nuclear RNA foci in the heart in myotonic dystrophy. Circ. Res. 97, 1152\u20131155 (2005).","journal-title":"Circ. Res."},{"key":"37619_CR7","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1093\/emboj\/19.17.4439","volume":"19","author":"JW Miller","year":"2000","unstructured":"Miller, J. W. et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 19, 4439\u20134448 (2000).","journal-title":"EMBO J."},{"key":"37619_CR8","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1093\/hmg\/ddl132","volume":"15","author":"X Lin","year":"2006","unstructured":"Lin, X. et al. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet. 15, 2087\u20132097 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"37619_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nsmb.1720","volume":"17","author":"H Du","year":"2010","unstructured":"Du, H. et al. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat. Struct. Mol. Biol. 17, 187\u2013193 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"37619_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.molcel.2014.08.027","volume":"56","author":"R Batra","year":"2014","unstructured":"Batra, R. et al. Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease. Mol. Cell 56, 311\u2013322 (2014).","journal-title":"Mol. Cell"},{"key":"37619_CR11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1101\/gr.184390.114","volume":"25","author":"ET Wang","year":"2015","unstructured":"Wang, E. T. et al. Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins. Genome Res. 25, 858\u2013871 (2015).","journal-title":"Genome Res."},{"key":"37619_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1097-2765(02)00563-4","volume":"10","author":"A Mankodi","year":"2002","unstructured":"Mankodi, A. et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10, 35\u201344 (2002).","journal-title":"Mol. Cell"},{"key":"37619_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1097-2765(02)00572-5","volume":"10","author":"BN Charlet","year":"2002","unstructured":"Charlet, B. N. et al. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell 10, 45\u201353 (2002).","journal-title":"Mol. Cell"},{"key":"37619_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1085\/jgp.200609635","volume":"129","author":"JD Lueck","year":"2007","unstructured":"Lueck, J. D., Mankodi, A., Swanson, M. S., Thornton, C. A. & Dirksen, R. T. Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy. J. Gen. Physiol. 129, 79\u201394 (2007).","journal-title":"J. Gen. Physiol"},{"key":"37619_CR15","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1152\/physrev.00031.2010","volume":"91","author":"S Schiaffino","year":"2011","unstructured":"Schiaffino, S. & Reggiani, C. Fiber types in mammalian skeletal muscles. Physiol. Rev. 91, 1447\u20131531 (2011).","journal-title":"Physiol. Rev."},{"key":"37619_CR16","doi-asserted-by":"publisher","first-page":"C93","DOI":"10.1152\/ajpcell.1991.261.1.C93","volume":"261","author":"L Larsson","year":"1991","unstructured":"Larsson, L., Edstrom, L., Lindegren, B., Gorza, L. & Schiaffino, S. MHC composition and enzyme-histochemical and physiological properties of a novel fast-twitch motor unit type. Am. J. Physiol. 261, C93\u2013C101 (1991).","journal-title":"Am. J. Physiol."},{"key":"37619_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF01739810","volume":"10","author":"S Schiaffino","year":"1989","unstructured":"Schiaffino, S. et al. Three myosin heavy chain isoforms in type 2 skeletal muscle fibres. J. Muscle. Res. Cell Motil. 10, 197\u2013205 (1989).","journal-title":"J. Muscle. Res. Cell Motil."},{"key":"37619_CR18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/mus.880110504","volume":"11","author":"J Reininghaus","year":"1988","unstructured":"Reininghaus, J., Fuchtbauer, E. M., Bertram, K. & Jockusch, H. The myotonic mouse mutant ADR: physiological and histochemical properties of muscle. Muscle Nerve 11, 433\u2013439 (1988).","journal-title":"Muscle Nerve"},{"key":"37619_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/BF00640912","volume":"406","author":"G Salviati","year":"1986","unstructured":"Salviati, G., Biasia, E., Betto, R. & Danieli Betto, D. Fast to slow transition induced by experimental myotonia in rat EDL muscle. Pflugers Arch. 406, 266\u2013272 (1986).","journal-title":"Pflugers Arch"},{"key":"37619_CR20","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/jnnp.50.8.1036","volume":"50","author":"J Borg","year":"1987","unstructured":"Borg, J., Edstrom, L., Butler-Browne, G. S. & Thornell, L. E. Muscle fibre type composition, motoneuron firing properties, axonal conduction velocity and refractory period for foot extensor motor units in dystrophia myotonica. J. Neurol. Neurosurg. Psychiatry 50, 1036\u20131044 (1987).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"37619_CR21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/mus.880170911","volume":"17","author":"H Tohgi","year":"1994","unstructured":"Tohgi, H., Kawamorita, A., Utsugisawa, K., Yamagata, M. & Sano, M. Muscle histopathology in myotonic dystrophy in relation to age and muscular weakness. Muscle Nerve 17, 1037\u20131043 (1994).","journal-title":"Muscle Nerve"},{"key":"37619_CR22","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1126\/science.289.5485.1769","volume":"289","author":"A Mankodi","year":"2000","unstructured":"Mankodi, A. et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289, 1769\u20131773 (2000).","journal-title":"Science"},{"key":"37619_CR23","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1126\/science.1088583","volume":"302","author":"RN Kanadia","year":"2003","unstructured":"Kanadia, R. N. et al. A muscleblind knockout model for myotonic dystrophy. Science 302, 1978\u20131980 (2003).","journal-title":"Science"},{"key":"37619_CR24","first-page":"3952","volume":"117","author":"TM Wheeler","year":"2007","unstructured":"Wheeler, T. M., Lueck, J. D., Swanson, M. S., Dirksen, R. T. & Thornton, C. A. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J. Clin. Invest. 117, 3952\u20133957 (2007).","journal-title":"J. Clin. Invest."},{"key":"37619_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.omtn.2020.11.014","volume":"23","author":"N Hu","year":"2021","unstructured":"Hu, N. et al. Antisense oligonucleotide and adjuvant exercise therapy reverse fatigue in old mice with myotonic dystrophy. Mol. Ther. Nucleic Acids 23, 393\u2013405 (2021).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"37619_CR26","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/emmm.201303275","volume":"5","author":"KY Lee","year":"2013","unstructured":"Lee, K. Y. et al. Compound loss of muscleblind-like function in myotonic dystrophy. EMBO Mol. Med. 5, 1887\u20131900 (2013).","journal-title":"EMBO Mol. Med."},{"key":"37619_CR27","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1152\/jappl.2001.90.5.1900","volume":"90","author":"DL Allen","year":"2001","unstructured":"Allen, D. L. et al. Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse. J. Appl. Physiol. (1985) 90, 1900\u20131908 (2001).","journal-title":"J. Appl. Physiol. (1985)"},{"key":"37619_CR28","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/hmg\/ddr568","volume":"21","author":"ZZ Tang","year":"2012","unstructured":"Tang, Z. Z. et al. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel. Hum. Mol. Genet. 21, 1312\u20131324 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"37619_CR29","doi-asserted-by":"publisher","first-page":"e1006316","DOI":"10.1371\/journal.pgen.1006316","volume":"12","author":"SD Wagner","year":"2016","unstructured":"Wagner, S. D. et al. Dose-dependent regulation of alternative splicing by MBNL proteins reveals biomarkers for myotonic dystrophy. PLoS Genet. 12, e1006316 (2016).","journal-title":"PLoS Genet."},{"key":"37619_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07517-y","volume":"9","author":"N Hu","year":"2018","unstructured":"Hu, N. et al. Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1. Nat. Commun. 9, 5227 (2018).","journal-title":"Nat. Commun."},{"key":"37619_CR31","doi-asserted-by":"publisher","first-page":"e0162467","DOI":"10.1371\/journal.pone.0162467","volume":"11","author":"RC Verheul","year":"2016","unstructured":"Verheul, R. C., van Deutekom, J. C. & Datson, N. A. Digital droplet PCR for the absolute quantification of exon skipping induced by antisense oligonucleotides in (pre-)clinical development for duchenne muscular dystrophy. PLoS ONE 11, e0162467 (2016).","journal-title":"PLoS ONE"},{"key":"37619_CR32","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/labinvest.2010.98","volume":"90","author":"P Spitali","year":"2010","unstructured":"Spitali, P. et al. Accurate quantification of dystrophin mRNA and exon skipping levels in duchenne muscular dystrophy. Lab. Invest. 90, 1396\u20131402 (2010).","journal-title":"Lab. Invest"},{"key":"37619_CR33","doi-asserted-by":"publisher","first-page":"e0204485","DOI":"10.1371\/journal.pone.0204485","volume":"13","author":"M Hiller","year":"2018","unstructured":"Hiller, M. et al. A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures. PLoS ONE 13, e0204485 (2018).","journal-title":"PLoS ONE"},{"key":"37619_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/mus.880090413","volume":"9","author":"GE Moore","year":"1986","unstructured":"Moore, G. E., Roses, A. D., Pericak-Vance, M. A., Garrett, W. E. Jr. & Schachat, F. H. Promiscuous expression of myosin in myotonic dystrophy. Muscle Nerve 9, 355\u2013363 (1986).","journal-title":"Muscle Nerve"},{"key":"37619_CR35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1212\/WNL.36.5.693","volume":"36","author":"G Salviati","year":"1986","unstructured":"Salviati, G. et al. Myosin light chains and muscle pathology. Neurology 36, 693\u2013697 (1986).","journal-title":"Neurology"},{"key":"37619_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0022-510X(87)90206-1","volume":"77","author":"Y Tanabe","year":"1987","unstructured":"Tanabe, Y. & Nonaka, I. Congenital myotonic dystrophy. Changes in muscle pathology with ageing. J. Neurol. Sci. 77, 59\u201368 (1987).","journal-title":"J. Neurol. Sci."},{"key":"37619_CR37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.nmd.2004.06.008","volume":"14","author":"A Briguet","year":"2004","unstructured":"Briguet, A., Courdier-Fruh, I., Foster, M., Meier, T. & Magyar, J. P. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul. Disord. 14, 675\u2013682 (2004).","journal-title":"Neuromuscul. Disord."},{"key":"37619_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature11362","volume":"488","author":"TM Wheeler","year":"2012","unstructured":"Wheeler, T. M. et al. Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488, 111\u2013115 (2012).","journal-title":"Nature"},{"key":"37619_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ana.410350116","volume":"35","author":"CA Thornton","year":"1994","unstructured":"Thornton, C. A., Johnson, K. & Moxley, R. T. III Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann. Neurol. 35, 104\u2013107 (1994).","journal-title":"Ann. Neurol"},{"key":"37619_CR40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/hmg\/4.3.401","volume":"4","author":"M Zatz","year":"1995","unstructured":"Zatz, M. et al. Analysis of the CTG repeat in skeletal muscle of young and adult myotonic dystrophy patients: when does the expansion occur? Hum. Mol. Genet. 4, 401\u2013406 (1995).","journal-title":"Hum. Mol. Genet."},{"key":"37619_CR41","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/ana.23992","volume":"74","author":"M Nakamori","year":"2013","unstructured":"Nakamori, M. et al. Splicing biomarkers of disease severity in myotonic dystrophy. Ann. Neurol. 74, 862\u2013872 (2013).","journal-title":"Ann. Neurol"},{"key":"37619_CR42","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1126\/science.1173110","volume":"325","author":"TM Wheeler","year":"2009","unstructured":"Wheeler, T. M. et al. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 325, 336\u2013339 (2009).","journal-title":"Science"},{"key":"37619_CR43","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1080\/15476286.2022.2066334","volume":"19","author":"A Holm","year":"2022","unstructured":"Holm, A., Hansen, S. N., Klitgaard, H. & Kauppinen, S. Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases. RNA Biol. 19, 594\u2013608 (2022).","journal-title":"RNA Biol"},{"key":"37619_CR44","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1093\/nar\/gkz354","volume":"47","author":"TP Prakash","year":"2019","unstructured":"Prakash, T. P. et al. Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle. Nucleic Acids Res. 47, 6029\u20136044 (2019).","journal-title":"Nucleic Acids Res."},{"key":"37619_CR45","first-page":"6045","volume":"47","author":"ME Ostergaard","year":"2019","unstructured":"Ostergaard, M. E. et al. Conjugation of hydrophobic moieties enhances potency of antisense oligonucleotides in the muscle of rodents and non-human primates. Nucleic Acids Res. 47, 6045\u20136058 (2019).","journal-title":"Nucleic Acids Res."},{"key":"37619_CR46","doi-asserted-by":"publisher","first-page":"4739","DOI":"10.1172\/JCI128205","volume":"129","author":"AF Klein","year":"2019","unstructured":"Klein, A. F. et al. Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice. J. Clin. Invest. 129, 4739\u20134744 (2019).","journal-title":"J. Clin. Invest."},{"key":"37619_CR47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/d41573-021-00213-5","volume":"21","author":"A Mullard","year":"2022","unstructured":"Mullard, A. Antibody-oligonucleotide conjugates enter the clinic. Nat. Rev. Drug Discov. 21, 6\u20138 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"37619_CR48","doi-asserted-by":"publisher","first-page":"11401","DOI":"10.1093\/nar\/gkac641","volume":"50","author":"CA Desjardins","year":"2022","unstructured":"Desjardins, C. A. et al. Enhanced exon skipping and prolonged dystrophin restoration achieved by TfR1-targeted delivery of antisense oligonucleotide using FORCE conjugation in mdx mice. Nucleic Acids Res. 50, 11401\u201311414 (2022).","journal-title":"Nucleic Acids Res."},{"key":"37619_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.omtn.2022.08.019","volume":"30","author":"L Gan","year":"2022","unstructured":"Gan, L. et al. A cell-penetrating peptide enhances delivery and efficacy of phosphorodiamidate morpholino oligomers in mdx mice. Mol. Ther. Nucleic Acids 30, 17\u201327 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"37619_CR50","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.omtn.2022.10.025","volume":"30","author":"LV Gushchina","year":"2022","unstructured":"Gushchina, L. V. et al. Systemic PPMO-mediated dystrophin expression in the Dup2 mouse model of Duchenne muscular dystrophy. Mol. Ther. Nucleic Acids 30, 479\u2013492 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"37619_CR51","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1212\/WNL.0000000000011002","volume":"96","author":"C Heatwole","year":"2021","unstructured":"Heatwole, C. et al. Mexiletine in myotonic dystrophy type 1: a randomized, double-blind, placebo-controlled trial. Neurology 96, e228\u2013e240 (2021).","journal-title":"Neurology"},{"key":"37619_CR52","doi-asserted-by":"publisher","first-page":"e014006","DOI":"10.1161\/JAHA.119.014006","volume":"9","author":"EM McNally","year":"2020","unstructured":"McNally, E. M. et al. Clinical care recommendations for cardiologists treating adults with myotonic dystrophy. J. Am. Heart Assoc. 9, e014006 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"37619_CR53","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1093\/nar\/gkab022","volume":"49","author":"MK Tanner","year":"2021","unstructured":"Tanner, M. K., Tang, Z. & Thornton, C. A. Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy. Nucleic Acids Res. 49, 2240\u20132254 (2021).","journal-title":"Nucleic Acids Res."},{"key":"37619_CR54","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1074\/jbc.M410781200","volume":"280","author":"W Dansithong","year":"2005","unstructured":"Dansithong, W., Paul, S., Comai, L. & Reddy, S. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J. Biol. Chem. 280, 5773\u20135780 (2005).","journal-title":"J. Biol. Chem."},{"key":"37619_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1085\/jgp.201010496","volume":"137","author":"M DiFranco","year":"2011","unstructured":"DiFranco, M., Herrera, A. & Vergara, J. L. Chloride currents from the transverse tubular system in adult mammalian skeletal muscle fibers. J. Gen. Physiol. 137, 21\u201341 (2011).","journal-title":"J. Gen. Physiol."},{"key":"37619_CR56","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1085\/jgp.201010526","volume":"136","author":"JD Lueck","year":"2010","unstructured":"Lueck, J. D., Rossi, A. E., Thornton, C. A., Campbell, K. P. & Dirksen, R. T. Sarcolemmal-restricted localization of functional ClC-1 channels in mouse skeletal muscle. J. Gen. Physiol. 136, 597\u2013613 (2010).","journal-title":"J. Gen. Physiol."},{"key":"37619_CR57","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3389\/fphar.2020.00714","volume":"11","author":"E Conte","year":"2020","unstructured":"Conte, E. et al. Changes in expression and cellular localization of rat skeletal muscle ClC-1 chloride channel in relation to age, myofiber phenotype and PKC modulation. Front. Pharmacol. 11, 714 (2020).","journal-title":"Front. Pharmacol."},{"key":"37619_CR58","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1093\/hmg\/10.19.2165","volume":"10","author":"A Mankodi","year":"2001","unstructured":"Mankodi, A. et al. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet. 10, 2165\u20132170 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"37619_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06206-0","volume":"9","author":"L Antoury","year":"2018","unstructured":"Antoury, L. et al. Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies. Nat. Commun. 9, 3906 (2018).","journal-title":"Nat. Commun."},{"key":"37619_CR60","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/bioinformatics\/btm091","volume":"23","author":"T Koressaar","year":"2007","unstructured":"Koressaar, T. & Remm, M. Enhancements and modifications of primer design program Primer3. Bioinformatics 23, 1289\u20131291 (2007).","journal-title":"Bioinformatics"},{"key":"37619_CR61","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser, A. et al. Primer3\u2013new capabilities and interfaces. Nucleic Acids Res. 40, e115 (2012).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37619-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37619-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37619-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T09:04:09Z","timestamp":1680858249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37619-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37619"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-37619-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,7]]},"assertion":[{"value":"4 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1956"}}